Astrotech Corporation (NASDAQ:ASTC – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $3.19 and traded as low as $2.32. Astrotech shares last traded at $2.47, with a volume of 73,907 shares.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings cut shares of Astrotech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Astrotech has a consensus rating of “Sell”.
View Our Latest Stock Analysis on Astrotech
Astrotech Trading Up 8.3%
Astrotech (NASDAQ:ASTC – Get Free Report) last announced its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) earnings per share for the quarter. Astrotech had a negative return on equity of 81.85% and a negative net margin of 1,397.82%.The company had revenue of $0.34 million during the quarter.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the stock. Susquehanna International Group LLP acquired a new position in Astrotech during the 3rd quarter worth $66,000. DRW Securities LLC increased its stake in shares of Astrotech by 168.5% in the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after buying an additional 19,747 shares during the period. Finally, J. Safra Sarasin Holding AG acquired a new stake in shares of Astrotech in the 1st quarter valued at $140,000. Institutional investors own 24.35% of the company’s stock.
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Featured Articles
- Five stocks we like better than Astrotech
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
